New Delhi, December 17, 2019:
Diabetic nephropathy or overt proteinuria (macroalbuminuria, or “severely increased albuminuria”) is usually present with worse glycemic control, hypertension, glomerular hyperfiltration, or a genetic predisposition.
The earliest clinical manifestation of renal involvement in diabetes is an increase in albumin excretion (microalbuminuria, or “moderately increased albuminuria”)
Glycemic control can partially reverse the glomerular hypertrophy and hyperfiltration, delay the development of elevated albumin excretion, stabilize or decrease protein excretion in patients with increased albumin excretion, and can slow the progression of glomerular filtration rate decline.
ACE inhibitors OR ARBs can reduce the rate of kidney disease progression.
Do not combiner the two.
Also do not combine aliskiren, a direct renin inhibitor with ACE or ARBs.
Diabetic nephropathy with EGFR >30 mL/min per 1.73 m2 add SGLT-2 inhibitor canagliflozin or
Dr KK Aggarwal
President CMAAO and HCFI